๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The problem of detecting and managing depression in the rheumatology clinic

โœ Scribed by Nicassio, Perry M.


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
50 KB
Volume
59
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Detection and management of depression i
โœ Mavis Evans ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 617 KB

Depression is common in the elderly especially the elderly physically ill. It is a condition with high morbidity and mortality, especially if untreated. Depression at all ages costs society many millions of pounds for drug, GP and hospitalisation costs. In the elderly these costs can be compounded b

The problem behavior model: the developm
โœ Lisa J. Warren; Rachel MacKenzie; Paul E. Mullen; James R. P. Ogloff ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 2 views

## Abstract Traditionally, forensic mental health services have focused on the assessment and treatment of offenders with serious mental disorders. In recent years, there has been growing recognition that forensic clinicians have an important role to play for those offenders who engage in criminal

Dimensions of the Beck depression invent
โœ Robert A. Steer; Roberta Ball; William F. Ranieri; Aaron T. Beck ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 2 views

To ascertain the dimensions of the Beck Depression Inventory-II (BDI-II;Beck, Steer, & Brown, 1996) in clinically depressed outpatients, exploratory factor analyses were performed with the BDI-II responses of 210 adult (ี†18 years) outpatients who were diagnosed with DSM-IV depressive disorders. Two

Unmet needs in the pharmacological manag
โœ David S. Baldwin ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB

Newer antidepressants, such as the selective serotonin reuptake inhibitors (SSRIs), selective noradrenaline reuptake inhibitors (NRIs) and drugs acting on both serotonin and noradrenaline, represent a clinically significant advance over the tricyclic antidepressants (TCAs) and monoamine oxidase inhi